GENZYME CORP Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
GENZYME CORP had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $395.21 billion as of 2010-12-31, per its 10-K filed 2011-03-01.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2011-03-01
- 2010-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $395.21B.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value |
|---|---|
| 2010-12-31 | $395.21B 10-K · filed 2011-03-01 |